NLTX insider filings
Neoleukin Therapeutics, Inc. — 10 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-10-10. Screen NLTX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for NLTX between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Neoleukin Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-10-10 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner | Option exercise/expiry (X): 57,049 · Option exercise/expiry (X): 535,601 · Option exercise/expiry (X): 57,049 (derivative) @ $0 · Option exercise/expiry (X): 535,601 (derivative) @ $0 | EDGAR |
| 2023-08-17 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner 667, L.P. — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner | Purchase (P): 143,519 @ $0.63 · Purchase (P): 1,740,581 @ $0.63 · Purchase (P): 358 @ $0.67 · Purchase (P): 4,342 @ $0.67 · Purchase (P): 17,124 @ $0.68 · Purchase (P): 207,676 @ $0.68 · +6 more | EDGAR |
| 2023-08-14 | 4 | Smith Sean Michael — Interim CFO, Prin Acct Off | Option exercise (M): 5,000 @ $0 · Sale (S): 1,323 @ $0.62 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | BAKER BROS. ADVISORS LP — Director 667, L.P. — Director Baker Brothers Life Sciences LP — Director BAKER FELIX — Director BAKER JULIAN — Director Baker Bros. Advisors (GP) LLC — Director | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | PALEKAR ROHAN — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Noonberg Sarah B. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Lavelle Erin — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Babler Martin — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | SIMPSON TODD E — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Patel Priti | Option exercise (M): 10,000 @ $0 · Sale (S): 3,769 @ $0.69 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Neoleukin Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NLTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →